What is the BPC-157 + TB-500 Blend?

This advanced research formulation combines BPC-157 (10 mg) and TB-500 (Thymosin Beta-4 Acetate, 10 mg) in a single vial, providing a total of 20 mg of high-purity peptide material. Designed exclusively for in vitro research, this blend is used to investigate cellular signalling, actin modulation, and tissue modelling pathways. Supplied in a lyophilised format to ensure long-term stability and precision.

Research Applications

• Investigation of peptide-based cellular response
• Research into actin-binding proteins and cellular migration
• Studies on combined peptide signalling pathways
• Peptide interaction modelling in laboratory environments

Key Features

• Dual peptide blend: BPC-157 and TB-500
• Total content: 20 mg per vial
• ≥98% purity (HPLC verified)
• Lyophilised formulation for optimal research stability
• Batch-specific Certificate of Analysis available

Specifications

Reconstitution & Handling

• Reconstitute with bacteriostatic water or suitable solvent
• Gently swirl until fully dissolved
• Aliquot immediately if storing to prevent peptide degradation

Quality & Testing

Each vial of BPC-157 + TB-500 is verified using high-performance liquid chromatography (HPLC) and mass spectrometry to confirm identity and ≥98% purity. Batch-level traceability is provided, and Certificates of Analysis (COAs) are available upon request.

Important Notice

For laboratory research use only. This peptide formulation is not intended for human consumption, therapeutic use, or diagnostic purposes.